{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T05:40:18Z","timestamp":1695447618443},"reference-count":43,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3314\/mmj.16.006","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T22:23:13Z","timestamp":1480371793000},"page":"J155-J162","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis and Treatment of Mucormycosis in Patients with Hematological Malignancies"],"prefix":"10.3314","volume":"57","author":[{"given":"Yuki","family":"Asano-Mori","sequence":"first","affiliation":[{"name":"Department of Hematology, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European Conference on Infections in Leukemia: Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 98: 492-504, 2013.","DOI":"10.3324\/haematol.2012.065110"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Cornely OA, Arikan-Akdagli S, Dannaoui E, et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20 Suppl 3: 5-26, 2014.","DOI":"10.1111\/1469-0691.12371"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V: The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 44: 335-342, 2006.","DOI":"10.1080\/13693780500464930"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653, 2005.","DOI":"10.1086\/432579"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kontoyiannis DP, Marr KA, Park BJ, et al: Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50: 1091-1100, 2010.","DOI":"10.1086\/651263"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Girmenia C, Raiola AM, Piciocchi A, et al: Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 20: 872-880, 2014.","DOI":"10.1016\/j.bbmt.2014.03.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K: Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48: 265-273, 2009.","DOI":"10.1086\/595846"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Park BJ, Pappas PG, Wannemuehler KA, et al: Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 17: 1855-1864, 2011.","DOI":"10.3201\/eid1710.110087"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kontoyiannis DP, Azie N, Franks B, Horn DL: Prospective antifungal therapy (PATH) alliance\u00ae: focus on mucormycosis. Mycoses 57: 240-246, 2014.","DOI":"10.1111\/myc.12149"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Skiada A, Pagano L, Groll A, et al; European Confederation of Medical Mycology Working Group on Zygomycosis: Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17: 1859-1867, 2011.","DOI":"10.1111\/j.1469-0691.2010.03456.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O; French Mycosis Study Group: A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis 54 Suppl 1: S35-43, 2012.","DOI":"10.1093\/cid\/cir880"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mori T, Yahata Y, Tsukune Y: [Zygomycosis]. Med Mycol J 52: 283-289, 2011.","DOI":"10.3314\/mmj.52.283"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP: Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54 Suppl 1: S23-34, 2012.","DOI":"10.1093\/cid\/cir866"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kontoyiannis DP, Lewis RE: How I treat mucormycosis. Blood 118: 1216-1224, 2011.","DOI":"10.1182\/blood-2011-03-316430"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II: Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-1360, 2005.","DOI":"10.1086\/428780"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Ibrahim AS, Kontoyiannis DP: Update on mucormycosis pathogenesis. Curr Opin Infect Dis 26: 508-515, 2013.","DOI":"10.1097\/QCO.0000000000000008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP: Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 39: 425-429, 2007.","DOI":"10.1038\/sj.bmt.1705614"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA: Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 39: 584-587, 2004.","DOI":"10.1086\/422723"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Legouge C, Caillot D, Chr\u00e9tien ML, Lafon I, Ferrant E, Audia S, Pag\u00e8s PB, Roques M, Estivalet L, Martin L, Maitre T, Bastie JN, Dalle F: The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin Infect Dis 58: 672-678, 2014.","DOI":"10.1093\/cid\/cit929"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP: Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 41: 60-66, 2005.","DOI":"10.1086\/430710"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Kimura M, Araoka H, Uchida N, Ohno H, Miyazaki Y, Fujii T, Nishida A, Izutsu K, Wake A, Taniguchi S, Yoneyama A: Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation. Med Mycol 50: 412-416, 2012.","DOI":"10.3109\/13693786.2011.631153"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Lass-Fl\u00f6rl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, Bialek R, Freund MC: The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 45: e101-104, 2007.","DOI":"10.1086\/521245"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP: Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 54 Suppl 1: S55-60, 2012.","DOI":"10.1093\/cid\/cir868"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Gomes MZ, Lewis RE, Kontoyiannis DP: Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 24: 411-445, 2011.","DOI":"10.1128\/CMR.00056-10"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O: Healthcare-associated mucormycosis. Clin Infect Dis 54 Suppl 1: S44-54, 2012.","DOI":"10.1093\/cid\/cir867"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 348-359, 2007.","DOI":"10.1056\/NEJMoa061094"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S: Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335-347, 2007.","DOI":"10.1056\/NEJMoa061098"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M: Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect 20: O952-959, 2014.","DOI":"10.1111\/1469-0691.12688"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP: Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis 199: 1399-1406, 2009.","DOI":"10.1086\/597615"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O; French Mycosis Study Group: Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis. J Antimicrob Chemother 70: 3116-3123, 2015.","DOI":"10.1093\/jac\/dkv236"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Chamilos G, Lewis RE, Kontoyiannis DP: Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47: 503-509, 2008.","DOI":"10.1086\/590004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33) van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 42: e61-65, 2006.","DOI":"10.1086\/500212"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Greenberg RN, Mullane K, van Burik JA, et al: Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 50: 126-133, 2006.","DOI":"10.1128\/AAC.50.1.126-133.2006"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Marty FM, Ostrosky-Zeichner L, Cornely OA, et al; VITAL and FungiScope Mucormycosis Investigators: Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis 16: 828-837, 2016.","DOI":"10.1016\/S1473-3099(16)00071-2"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Pagano L, Cornely OA, Busca A, et al: Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries. Haematologica 98: e127-130, 2013.","DOI":"10.3324\/haematol.2012.083063"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B: Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47: 364-371, 2008.","DOI":"10.1086\/589857"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Abidi MZ, Sohail MR, Cummins N, et al: Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses 57: 687-698, 2014.","DOI":"10.1111\/myc.12222"},{"key":"38","doi-asserted-by":"publisher","unstructured":"39) Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP: Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect, 2016. doi: 10.1016\/j.cmi.2016.03.029. [Epub ahead of print]","DOI":"10.1016\/j.cmi.2016.03.029"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40) Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67: 715-722, 2012.","DOI":"10.1093\/jac\/dkr375"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F; French Mycosis Study Group: Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival. Clin Microbiol Infect 20: O336-339, 2014.","DOI":"10.1111\/1469-0691.12408"},{"key":"41","doi-asserted-by":"publisher","unstructured":"42) Chretien ML, Legouge C, Pag\u00e8s PB, Lafon I, Ferrant E, Plocque A, Favennec C, Estivalet L, Bottolier-Lemallaz E, Dalle F, Bastie JN, Bernard A, Caillot D: Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre. Clin Microbiol Infect, 2016. doi:10.1016\/j.cmi.2015.12.029. [Epub ahead of print]","DOI":"10.1016\/j.cmi.2015.12.029"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE: Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 57: 1044-1050, 1994.","DOI":"10.1016\/0003-4975(94)90243-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44) Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP: Risk factors for mortality in patients with mucormycosis. Med Mycol 50: 611-618, 2012.","DOI":"10.3109\/13693786.2012.669502"}],"container-title":["Medical Mycology Journal"],"original-title":["\u8840\u6db2\u75be\u60a3\u306b\u304a\u3051\u308b\u30e0\u30fc\u30b3\u30eb\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/4\/57_16.006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:40:44Z","timestamp":1498365644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/4\/57_16.006\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.16.006","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}